BMNDF
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jun 25 closing price
Capitalization
19.79M
CLVLY
Price
$6.80
Change
-$0.18 (-2.58%)
Updated
Jun 27 closing price
Capitalization
339M
Interact to see
Advertisement

BMNDF vs CLVLY

Header iconBMNDF vs CLVLY Comparison
Open Charts BMNDF vs CLVLYBanner chart's image
BIOMIND LABS
Price$0.10
Change-$0.00 (-0.00%)
Volume$4.02K
Capitalization19.79M
Clinuvel Pharmaceuticals
Price$6.80
Change-$0.18 (-2.58%)
Volume$161
Capitalization339M
BMNDF vs CLVLY Comparison Chart in %
Loading...
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLVLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMNDF vs. CLVLY commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMNDF is a Hold and CLVLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (BMNDF: $0.10 vs. CLVLY: $6.80)
Brand notoriety: BMNDF and CLVLY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMNDF: 326% vs. CLVLY: 14%
Market capitalization -- BMNDF: $19.79M vs. CLVLY: $339M
BMNDF [@Biotechnology] is valued at $19.79M. CLVLY’s [@Biotechnology] market capitalization is $339M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMNDF’s FA Score shows that 0 FA rating(s) are green whileCLVLY’s FA Score has 1 green FA rating(s).

  • BMNDF’s FA Score: 0 green, 5 red.
  • CLVLY’s FA Score: 1 green, 4 red.
According to our system of comparison, CLVLY is a better buy in the long-term than BMNDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMNDF’s TA Score shows that 1 TA indicator(s) are bullish while CLVLY’s TA Score has 4 bullish TA indicator(s).

  • BMNDF’s TA Score: 1 bullish, 3 bearish.
  • CLVLY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CLVLY is a better buy in the short-term than BMNDF.

Price Growth

BMNDF (@Biotechnology) experienced а 0.00% price change this week, while CLVLY (@Biotechnology) price change was +7.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLVLY($339M) has a higher market cap than BMNDF($19.8M). CLVLY YTD gains are higher at: -11.688 vs. BMNDF (-67.490). CLVLY has higher annual earnings (EBITDA): 63.4M vs. BMNDF (-314.15K). CLVLY has higher revenues than BMNDF: CLVLY (91.6M) vs BMNDF (0).
BMNDFCLVLYBMNDF / CLVLY
Capitalization19.8M339M6%
EBITDA-314.15K63.4M-0%
Gain YTD-67.490-11.688577%
P/E RatioN/A13.61-
Revenue091.6M-
Total Cash10.1KN/A-
Total Debt883KN/A-
FUNDAMENTALS RATINGS
BMNDF vs CLVLY: Fundamental Ratings
BMNDF
CLVLY
OUTLOOK RATING
1..100
5058
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
10045
PRICE GROWTH RATING
1..100
9880
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLVLY's Valuation (3) in the null industry is significantly better than the same rating for BMNDF (96). This means that CLVLY’s stock grew significantly faster than BMNDF’s over the last 12 months.

BMNDF's Profit vs Risk Rating (92) in the null industry is in the same range as CLVLY (100). This means that BMNDF’s stock grew similarly to CLVLY’s over the last 12 months.

CLVLY's SMR Rating (45) in the null industry is somewhat better than the same rating for BMNDF (100). This means that CLVLY’s stock grew somewhat faster than BMNDF’s over the last 12 months.

CLVLY's Price Growth Rating (80) in the null industry is in the same range as BMNDF (98). This means that CLVLY’s stock grew similarly to BMNDF’s over the last 12 months.

CLVLY's P/E Growth Rating (94) in the null industry is in the same range as BMNDF (100). This means that CLVLY’s stock grew similarly to BMNDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMNDFCLVLY
RSI
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
69%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
31%
Bearish Trend 3 days ago
76%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
43%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
42%
Bullish Trend 3 days ago
61%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
64%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLVLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFIDX101.030.96
+0.96%
Fidelity
AGLCX7.140.05
+0.71%
American Century Focused Global Gr C
MCBAX14.570.10
+0.69%
BlackRock Large Cap Focus Value Inv C
DAFGX41.720.17
+0.41%
Dunham Focused Large Cap Growth A
SHEAX9.350.02
+0.21%
American Beacon Shapiro SMID Cap Eq A

BMNDF and

Correlation & Price change

A.I.dvisor tells us that BMNDF and CLVLY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMNDF and CLVLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMNDF
1D Price
Change %
BMNDF100%
N/A
CLVLY - BMNDF
26%
Poorly correlated
-2.58%
RGLS - BMNDF
24%
Poorly correlated
N/A
MLLCF - BMNDF
21%
Poorly correlated
N/A
VIGL - BMNDF
20%
Poorly correlated
N/A
CYDY - BMNDF
12%
Poorly correlated
-14.17%
More

CLVLY and

Correlation & Price change

A.I.dvisor tells us that CLVLY and BMNDF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLY and BMNDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLY
1D Price
Change %
CLVLY100%
-2.58%
BMNDF - CLVLY
26%
Poorly correlated
N/A
QLGN - CLVLY
21%
Poorly correlated
+0.28%
ZLAB - CLVLY
21%
Poorly correlated
-3.87%
MLEC - CLVLY
21%
Poorly correlated
-7.49%
HLVX - CLVLY
21%
Poorly correlated
+1.03%
More